Skip to main content
. 2021 Feb 9;314(1):1–15. doi: 10.1007/s00403-021-02190-6

Table 1.

Total Treatment summary for Case 2 patient over a 4 week course

Therapeutic intervention Dosage/caregiver
Recombinant hyaluronidase (Hylenex) 21.65 cc (150 U/cc dispensed in 1 vial)
Bovine hyaluronidase (compounded) 9.5 cc (150 U.cc)
Oral corticosteroids

Medrol DosePak

60 mg Prednisone taper over 12 days (60 mg × 4 days, 40 mg × 4 days x 20 mg × 4 days)

Oral antimicrobials

Generic Doxycycline capsules 100 mg BID × 7 days

Nitrofurantoin 100 mg BID × 7 days

Intralesional 5-fluorouracil 0.8 cc (50mc/cc)
Health care providers seen in consultation or treatment Oculoplastic surgeon, otolaryngology, nurse injector (at plastic surgery office), dermatologist

DIR after participating in mRNA 1273 Vaccine Trial